A rapid treatment model that included a 7-day starter pack of medication significantly increased hepatitis C cure rates among young people who inject drugs, according to a small study.“When a pathogenic infectious disease is diagnosed and well-tolerated curative therapy is available, treatment is typically not delayed,” Benjamin J. Eckhardt, MD, MS, assistant professor of infectious…
In a Healio interview, Douglas K. Rex, MD, president of ASGE and distinguished professor emeritus of medicine at Indiana University, details upcoming ASGE sessions that attendees should include on their agendas at Digestive Disease Week.Healio: After 2 years of virtual meetings, how does it feel to attend a live conference?Rex: I am really looking forward…
Concomitant proton pump inhibitor plus ticagrelor monotherapy after PCI does not increase risk for all-cause death or an adverse CV event, in contrast with conventional post-PCI antiplatelet therapy, researchers reported.In a post hoc analysis of the GLOBAL LEADERS trial, researchers found that patients taking a proton pump inhibitor (PPI) treated with the conventional post-PCI treatment…
Anti-tumor necrosis factor therapy had reduced efficacy and safety for bio-naive patients with older-onset inflammatory bowel disease compared with younger patients, according to a study published in Scientific Reports.“Anti-TNF treatment is effective for both the induction and maintenance of patients with IBD and improves their quality of life. The efficacy and safety of anti-TNF treatment…
The Florida Gastroenterologic Society was originally conceived in 1965 by James L. Borland, M.D., a well respected Gastroenterologist who practiced in Jacksonville, Florida.